4//SEC Filing
Faerm Michael E. 4
Accession 0000950170-24-061112
CIK 0001061027other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:26 PM ET
Size
5.9 KB
Accession
0000950170-24-061112
Insider Transaction Report
Form 4
Faerm Michael E.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-05-14+500,000→ 500,000 totalExercise: $0.80Exp: 2034-05-14→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the total shares subject to the Option will vest on the one (1)-year anniversary of the Vesting Commencement Date (as defined below) and 1/48th of the total shares subject to the Option will vest each month thereafter on the same day of the month as the Vesting Commencement Date, subject to the reporting person continuing to be a Service Provider in accordance with the Company's 2021 Inducement Equity Incentive Plan through each such date. The Vesting Commencement Date is May 13, 2024.
Documents
Issuer
Viracta Therapeutics, Inc.
CIK 0001061027
Entity typeother
Related Parties
1- filerCIK 0001647141
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:26 PM ET
- Size
- 5.9 KB